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Editorial on the Research Topic
Debates in Clinical Management in Pediatric Endocrinology
INTRODUCTION
Over the last decades the diagnosis andmanagement of pediatric endocrine disorders has substantially
improved. However, clinicians still face some key challenges, without straightforward solutions,
during their daily clinical practice.
This Research Topic includes a collection of papers on relevant topics in Pediatric Endocrinology
and Diabetes, which can support clinicians in better understanding endocrine conditions and
their management.
The global obesity epidemic has brought to light that metabolic complications, previously
thought to affect only obese adults, can manifest at a younger age. The true incidence of pediatric
type 2 diabetes (T2D) is still debated (1), and North American and European studies show
contrasting results. Indeed, the exponential increase in the incidence of T2D reported among North
American obese children and adolescents is not confirmed among European youth. Data from
different populations and Countries are essential to better understand the epidemiology of T2D. In
this issue, Al-Kandari et al. report the incidence of T2D in Kuwait, providing some Country-specific
unique epidemiological data.
The prevalence of glucokinase (GKC) deficit in pregnant women with diabetes is the focus of
Bitterman et al.’s paper. Although maturity onset diabetes of the young (MODY) due to GCK deficit
is a benign condition, a prompt diagnosis is essential for the optimal course of pregnancy and
planning of appropriate newborn care. Available data indicate that the prevalence of GKC deficit
varies between 0-80% among pregnant women, dependent on the screening criteria and the
populations’ characteristics (2, 3). In this retrospective study, the authors show that even the recent
“new-pregnancy-specific criteria,” based on BMI <25 kg/m2 and fasting glycemia >99 mg/dl, do not
reach optimal sensitivity and specificity thresholds. Therefore, better criteria applicable to different
populations, are required for a tailored selection of pregnant women eligible for genetic tests.
This issue also includes a systematic review and meta-analysis addressing the potential association
between type 1 diabetes (T1D) and periodontal disease in children (4). Previous studies reported an.org March 2021 | Volume 12 | Article 6638601
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with T2D and suggested a bidirectional relationship between these
two conditions. Rapone et al. highlight lack of strong evidence for
similar associations in children with T1D. Current evidence is
primarily based on cross-sectional studies, which show a higher
prevalence of periodontal disease in children with diabetes.
However, pediatric studies do not support a role of periodontal
disease in the pathogenesis of T1D and its complications and
exclude an effect on glycemic control.
The hypothalamic-pituitary-gonadal axis is discussed in
two comprehensive reviews. Bizzarri and Cappa offer an
interesting description of the transient sex-specific activation of
hypothalamic-pituitary-gonadal axis during the first 6 months of
life in boys, and the first 2 years in girls. This phenomenon, known
as “mini-puberty,” is fascinating and provides insights into the
understanding of the mechanisms of pubertal development later in
life. Festa et al. review genetic causes of pubertal delay and propose
a diagnostic algorithm to distinguish between self-limited delayed
puberty and other forms of hypogonadotropic hypogonadism.
Self-limited delayed puberty is a frequent condition in endocrine
clinical practice, whereas congenital hypogonadotropic
hypogonadism accounts for 4% and 5.7% cases of delayed
puberty in boys and girls, respectively. The authors offer an in-
depth discussion of the benefits and limitations of genetic testing
in the clinical setting, underling its potential role for a better
classification and management of delayed puberty.
Assessment of bone maturation (BM) in children and
adolescents is relevant in medical and non-medical fields (5).
Despite a few issues related to the use of different methods, bone
age is a unique tool to assess the maturational changes during
childhood and adolescence, and to aid the diagnostic workout of
growth disorders. In this Research Topic, Cavallo et al. provide
an overview of the main methods to assess bone age and discuss
their advantages and disadvantages. In a second paper, Pepe
et al. report the results of a prospective study assessing the linkFrontiers in Endocrinology | www.frontiersin.org 2between BM and postnatal growth during the first year of life in
a population of children born small for gestational age (SGA).
Although most SGA children show spontaneous catch-up
growth during the first two years of life, a percentage of them
remains short during childhood (6). In the present study, SGA
newborns with delayed BM showed greater growth velocities
and height gains at 12 months of age compared to those
with adequate BM at birth. Besides, the study shows that
ultrasonographic evaluation of the Béclard’s nucleus could
be a useful noninvasive technique to identify intrauterine
BM delay.
Another key topic discussed in this issue is the reason for and
appropriateness of pediatric endocrinology referrals. A clear
understanding of referral pathways is essential to optimize
resource use and plan continuous medical education and public
health interventions. Bellotto et al. report data on endocrine referrals
to a single Italian tertiary center for pediatric endocrinology. The
study highlights that growth and puberty represent nearly half of all
reasons for endocrine referrals, and that timing for referral (i.e.
urgent vs deferrable priority) is often inappropriate. The authors
suggest that medical education of primary care can be better tailored
to improve the timing of referral and the ability to recognize
subclinical and para-physiological conditions. These steps are
paramount to better define windows of intervention and optimize
clinical outcomes.
We hope that this Research Topic will provide a valuable
resource for the management of clinical endocrine issues in daily
practice and we encourage the readers to submit their General
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